Gene · 3624
INHBA: inhibin subunit beta A
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. INHBA: inhibin subunit beta A. Genes, record 3624. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3624
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P08476 | Inhibin beta A chain | 426 | 16 | Ensembl, GeneID, HGNC |
Source UniProt
Patents294
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 12637661 B2 | 2026-05-26 | 3 | P08476 | Espacenet |
| US 12637661 B2 | 2026-05-26 | 6 | P08476 | Espacenet |
| US 12630608 B2 | 2026-05-19 | 34 | P08476 | Espacenet |
| JP 2026062645 A | 2026-04-10 | 286 | P08476 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 185 | P08476 | Espacenet |
| EP 4698654 A1 | 2026-02-25 | 27 | P08476 | Espacenet |
| JP 2026503880 A | 2026-02-02 | 19 | P08476 | Espacenet |
| JP 2026503880 A | 2026-02-02 | 22 | P08476 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 49746 | P08476 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 49747 | P08476 | Espacenet |
1 to 10 of 294
See all 294 patentsDrugs2
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials39
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07600723 | SOTATERCEPT | PHASE4 | ClinicalTrials.gov | |
| NCT07559513 | GARETOSMAB | PHASE3 | ClinicalTrials.gov | |
| NCT07498803 | SOTATERCEPT | PHASE2 | ClinicalTrials.gov | |
| NCT07356778 | SOTATERCEPT | PHASE4 | ClinicalTrials.gov | |
| NCT07301450 | GARETOSMAB | ClinicalTrials.gov | ||
| NCT07266519 | SOTATERCEPT | PHASE2 | ClinicalTrials.gov | |
| NCT07218029 | SOTATERCEPT | PHASE3 | ClinicalTrials.gov | |
| NCT07140484 | SOTATERCEPT | PHASE4 | ClinicalTrials.gov | |
| NCT06925750 | SOTATERCEPT | PHASE2 | ClinicalTrials.gov | |
| NCT06814145 | SOTATERCEPT | PHASE2 | ClinicalTrials.gov |
1 to 10 of 39
See all 39 trialsNIH grants1,679
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | INHBA papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 7 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 6 | 2025 |
| T32CA009109 | Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies | 5 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 4 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 4 | 2025 |
| P50CA136393 | Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer | 4 | 2025 |
| R01HD032067 | Transforming growth factor β family signaling pathways in ovarian and uterine biology | 4 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 4 | 2025 |
1 to 10 of 1,679Source NIH's project files
See all 1,679 nih grantsPapers2,354
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Transcriptomic Analysis Identifies a Candidate INHBA/Activin A-Associated Macrophage-MuSC Communication Axis in Human Skeletal Muscle Ageing. | Int J Mol Sci | 2026 | 42794710 | PubTator, text mining | PubMed |
| Construction of an Esophageal Cancer Prognostic Model Based on Mitochondrial Energy Metabolism-Related Genes and Mechanism of INHBA in Promoting Malignant Progression via the Smad2/3 Pathway. | Biomolecules | 2026 | 42793200 | PubTator, text mining | PubMed |
| Integrating Multi-Omics and Machine Learning to Reveal a Prognostic Model for Prostate Cancer Metastatic Recurrence Associated with Epithelial-Mesenchymal Transition Features. | Genes (Basel) | 2026 | 42792911 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identifies Candidate Genomic Features Associated with Response to Platinum-Based Chemotherapy and Ixabepilone-Based Treatment in Ovarian Cancer. | Int J Mol Sci | 2026 | 42737428 | PubTator, text mining | PubMed |
| Single-Cell and Bulk Transcriptomic Integration Reveals an Adverse SPP1 Inflammatory TAM State and INHBA as a Candidate Biomarker in Non-Small Cell Lung Cancer Immunotherapy. | Int J Genomics | 2026 | 42656806 | PubTator, text mining | PubMed |
Identification of Progressive Islet Biomarkers for Type 2 Diabetes by Integrated Transcriptomics and Mendelian Randomization: Alterations Spanning the Normal Glucose Tolerance-Impaired Glucose Tolerance-Type 2 Diabetes Continuum. | Biomedicines | 2026 | 42652231 | PubTator, text mining | PubMed |
Correction to "Immune Gene INHBA is Associated With Osteoarthritic Cartilage Damage and May Mediate the Temporal Activation of the TGF-β/p38 MAPK Pathway: Integrating Multiomics Machine Learning and Experimental Validation". | Mediators Inflamm | 2026 | 42644660 | PubTator, text mining | PubMed |
| Single-cell RNA-seq and spatial transcriptomics characterize CD8+ exhausted T cells in pancreatic ductal adenocarcinoma. | iScience | 2026 | 42548877 | PubTator, text mining | PubMed |
| Systems-Level Mapping of the Tumor Microenvironment Reveals Immune-Mediated Mechanisms and Potential Targets in Platinum-Resistant Ovarian Cancer. | Res Sq | 2026 | 42539139 | PubTator, text mining | PubMed |
| Integrated transcriptomic and machine learning analysis identifies female-associated candidate biomarkers in Idiopathic pulmonary arterial hypertension. | Comput Biol Chem | 2026 | 42537335 | PubTator, text mining | PubMed |
1 to 10 of 2,354
See all 2,354 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3624
GET https://conductscience.org/api/genes/v1/3624/patents?page=2